• Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

    Nov 1, 2013, 00:00

  • Skeletal-Related Events Have a Significant Impact on Health-Related Quality of Life in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) Following Docetaxel Therapy Failure

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Cysteamine in the Treatment of Patients with Cystinosis – a Rare Disease

    Nov 1, 2013, 00:00

  • Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Health Care Cost of Controlled Versus Uncontrolled Type 2 Diabetes Patients in Greece

    Nov 1, 2013, 00:00

  • Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis for the Use of Extended Release Quetiapine as Adjunctive Therapy in Mexican Adult Patients with Major Depressive Disorder Non-Responders to Antidepressant Treatment

    Nov 1, 2013, 00:00

  • Estimates of Price and Income Elasticity in Gree Greek Debt Crisis Transforming Cigarettes into a Luxury Good

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Carbapenems in Treatment Nosocomian Pneumonia in Ukraine

    Nov 1, 2013, 00:00

  • Atopic Dermatitis- Evaluation of 2 Different Drug Related Managements

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ceftobiprole Compared to a Combination of Linezolid with Ceftazidime in the Management of Hospitalised Pneunomia in Scotland

    Nov 1, 2013, 00:00

  • Serious Adverse Events for Biologic Response Modifiers Indicated for the Prophylaxis Against Transplant Rejection. an Insight from Spontaneous Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • Modelling the Natural History of Schizophrenia- Comparison of Naïve Versus Advanced Statistical Methods

    Nov 1, 2013, 00:00

  • Guiding Principles for Effective Private Health Insurance in Emerging Markets

    Nov 1, 2013, 00:00

  • Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework

    Nov 1, 2013, 00:00

  • Barriers of Access to Elective Orthopedic Procedures in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Coronary Artery Disease, Diabetes, and Health-Related Quality of Life- Findings of a Cohort Study from India

    Nov 1, 2013, 00:00

  • Costs in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • Risk Factors for Discontinuation of Insulin Pump Therapy in Pediatric and Young Adult Patient Groups

    Nov 1, 2013, 00:00

  • Assessment of Cost-Effectiveness Models for Biologics in the Management of Severe Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom- Results from a Trial-Based Model

    Nov 1, 2013, 00:00

  • Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes- A Systematic Review

    Nov 1, 2013, 00:00

  • Linguistic Translation and Cultural Adaptation of Functional Assessment of Chronic Illness Therapy-Tuberculosis Instrument into Arabic Language

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine for Patients with Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand” (Dash) Questionnaire

    Nov 1, 2013, 00:00

  • Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

    Nov 1, 2013, 00:00

  • Health Economic (HE) Data Requirements and Availability in the European Union. Results of a Survey

    Nov 1, 2013, 00:00

  • Responder Analysis of Functional Health and Well-Being in MDD- A Pooled Analysis of SF-36 Results from Three Phase III Trials with Levomilnacipran SR

    Nov 1, 2013, 00:00

  • The Potential Impact of Amnog-Triggered International Referenc Pricing- A Scenario from DPP-IV Inhibitors

    Nov 1, 2013, 00:00

  • Budget Impact of Metastatic Castrate-Resistant Prostate Cancer (CRPC) to German Payers

    Nov 1, 2013, 00:00

  • Pet-Based Radiotherapy Treatment Planning Is Highly Cost-Effective Compared to CT-Based Planning- A Model-Based Evaluation

    Nov 1, 2013, 00:00

  • Should There Be an Option to “Unrefer” Nice Single Technology Appraisals- Case Study of Aripiprazole for Bipolar I Disorder in Adolescents

    Nov 1, 2013, 00:00

  • The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Chronic Kidney Disease in the United States

    Nov 1, 2013, 00:00

  • Multiple Imputation Techniques for Survey Data with Multiple Rating Scales

    Nov 1, 2013, 00:00

  • Dynamic Modeling to Estimate the Economic Impact of Increasing Influenza Vaccination in the United States

    Nov 1, 2013, 00:00

  • Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies

    Nov 1, 2013, 00:00

  • Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory

    Nov 1, 2013, 00:00

  • Diffusion of the Efficiency Frontier Approach Within Health Economic Evaluation- Current and Future Applications

    Nov 1, 2013, 00:00

  • Patient Survey Data Results- Preferences for Reminders in Pro Studies

    Nov 1, 2013, 00:00

  • A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

    Nov 1, 2013, 00:00

  • Evaluating Willingness-To-Pay Threshold for Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade- A Contingent Valuation Survey

    Nov 1, 2013, 00:00

  • Perfil De Adesão Aos Planos De Benefício Em Medicamentos

    Nov 1, 2013, 00:00

  • Crohn’s Disease- An Economic Assessment of Biological Drugs in Italy

    Nov 1, 2013, 00:00

  • Revised Scoring of the WPAI-Hep C Improves Assessment of Missed Work and Work Impairment in HCV Clinical Trials

    Nov 1, 2013, 00:00

  • Costs of Primary Biliary Cirrhosis Treatment with Ursodeoxycholic Acid in Brazil

    Nov 1, 2013, 00:00

  • The 2013 Revision to Nice’s Discounting Guidelines- Differential Discounting Has Gone But Unjustified Selective Application Remains

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Maternal Toxoplasma Screening in Austria- A Decision-analytic Model

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Drug Reimbursement in Germany

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fulvestrant 500 Mg Versus Generic Non-Steroidal Aromatase Inhibitors in Patients with Advanced Breast Cancer in Norway

    Nov 1, 2013, 00:00

  • Association Between Cognitive Function and 3 Month Health Care Costs Among Patients Initiating an Antidepressant for Depressive Disorder in an Ambulatory Care Setting

    Nov 1, 2013, 00:00

  • Quantifying Health Care Efficiency- A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

    Nov 1, 2013, 00:00

  • Quality Assessment of Observational Studies for Systematic Reviews

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease and Cost of Illness

    Nov 1, 2013, 00:00

  • Household Feeding Practices for the Sick Under Five Children; Gucha South District-Kisii County, Kenya

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Differences in the Weighted Average Daily Doses of Statins in Latin America and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2013, 00:00

  • A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United States

    Nov 1, 2013, 00:00

  • Current Situation of Oral Anticancer Treatments Use in Fran The Actor Study (Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Societal Unmet Needs in Brazil- Examining Prevalence, Treatment Rates, and Health Outcomes

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas 13-Valente Y 23-Valente Para Adultos De Alto Riesgo En Colombia

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

    Nov 1, 2013, 00:00

  • Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom

    Nov 1, 2013, 00:00

  • Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc Study

    Nov 1, 2013, 00:00

  • Análisis De Costo Efectividad De Acido Gadoterico Frente a Otros Medios De Contrastes Basados En Gadolinio

    Nov 1, 2013, 00:00

  • Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review

    Nov 1, 2013, 00:00

  • Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?

    Nov 1, 2013, 00:00

  • Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-Savings

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt

    Nov 1, 2013, 00:00

  • Construcción De Un Modelo De Priorización Aplicable a Latinoamérica – El Caso De Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Linezolid Comparado Con Vancomicina En El Manejo De La Neumonía Asociada A La Ventilación Mecanica En Colombia

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Intravenous Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Russia

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fluoroquinolone-Based Regimens for the Treatment of Community-Acquired Pneumonia in a Multi-Field Hospital in Russia

    Nov 1, 2013, 00:00

  • Different Discounting Approaches and Their Impact in Economic Evaluation- A Practical Example Using Hepatitis B Vaccination

    Nov 1, 2013, 00:00

  • ‘Big Data’ in Health Care. What Does It Mean and Will It Make a Difference?

    Nov 1, 2013, 00:00

  • Factorial Invariance of the Whoqol-Old Across Gender, Age, and Resident Area in Taiwan

    Nov 1, 2013, 00:00

  • ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT- RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Concomitant Aortic Valve Replacements in France and the United Kingdom

    Nov 1, 2013, 00:00

  • Uso De Bases De Datos O Sistemas De Información Para Soportar La Toma De Decisiones En Salud En Colombia

    Nov 1, 2013, 00:00

  • Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Addressing Childhood-Obesity in Mexico- Savings on Health Care Expenditures from Regulating Food and Beverage Sales in Basic Education Schools

    Nov 1, 2013, 00:00

  • A Comparative Study on the Cost of Antibiotics for the Years 2011-2012 in Three General Hospitals of Greece

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany

    Nov 1, 2013, 00:00

  • Japanese Representation in Leading General Medicine and Basic Science Journals- A Comparison of Two Decades

    Nov 1, 2013, 00:00

  • Evaluation of the Potential Efficacy of Ivabradine in Health Care of the Republic of Belarus

    Nov 1, 2013, 00:00

  • A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes- The Korea National Health and Nutrition Examination Survey

    Nov 1, 2013, 00:00

  • Update on Pharmacoeconomics in Nutrition- Parenteral Glutamine Supplement in Intensive Care Unit Patients

    Nov 1, 2013, 00:00

  • The Cost of Producing a Unit of Blood in Hospitals- A Nationwide Economic Analysis for the Case of Greece

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Agomelatine in Depressed Thai Patients Including the Elderly Depressed Population

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First Line Biologics for Rheumatoid Arthritis in Ireland

    Nov 1, 2013, 00:00

  • Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic Study

    Nov 1, 2013, 00:00

  • Economic Impact of a Smoking Cessation Program in Mexico- Enrolling Employees and Employers

    Nov 1, 2013, 00:00

  • Analysis and Classification of Risk-Sharing Schemes Proposed in Reimbursement Application Received by AHTAPol in 2012

    Nov 1, 2013, 00:00

  • Handling Variability in Time Endpoints in Multi-Centre Time and Motion (TM) Studies- A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in Italy

    Nov 1, 2013, 00:00

  • Correlation Between Prognostic Factors and Non Prosthetic Further Fracture Related Treatment After Femoral Neck Fracture Underwent Internal Fixation in Elderly

    Nov 1, 2013, 00:00

  • Trends in Chemotherapy Setting and Costs from 2005 to 2012- A Case Study Using Bevacizumab

    Nov 1, 2013, 00:00

  • Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)

    Nov 1, 2013, 00:00

  • Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy

    Nov 1, 2013, 00:00

  • Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Uptake of Denosumab in the Treatment of Osteoporosis in the Czech Republic

    Nov 1, 2013, 00:00

  • A Cost-Consequence Analysis of Different Protease Inhibitors Schemes for HIV Treatment from the Colombian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential Methods

    Nov 1, 2013, 00:00

  • Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 Countries

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia

    Nov 1, 2013, 00:00

  • How to Determine Size of Patient Population When the Right Data Isn’t There?

    Nov 1, 2013, 00:00

  • Investing in European Health RD – A Pathway to Sustained Innovation and Stronger Economies

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Liraglutide Versus Sitagliptin in Type 2 Diabetes in the United Kingdom- A Retrospective Study in Primary Care

    Nov 1, 2013, 00:00

  • Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0”

    Nov 1, 2013, 00:00

  • Costs of Hormonal Receptor Positive, Her 2 Negative Metastatic Breast Cancer (MBC-HR+) in Brazilian Private System (BPS)- A Real World and Published Literature Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Liraglutide for Treatment of Type 2 Diabetes Mellitus in the Russian Federation

    Nov 1, 2013, 00:00

  • What Are the Clinical and Economic Costs and Benefits of Implementing Point of Care Tests for Chlamydia Trachomatis and Neisseria Gonorrhoea in Genito-Urinary Medicine Clinics in the United Kingdom?

    Nov 1, 2013, 00:00

  • Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • The Association Between European Medicines Agency Approval and Health Technology Assessment Recommendation

    Nov 1, 2013, 00:00

  • Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)

    Nov 1, 2013, 00:00

  • Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data- The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

    Nov 1, 2013, 00:00

  • The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for Germany

    Nov 1, 2013, 00:00

  • Calidad De Prescripción De Antibióticos En El Servicio De Pediatria De Un Hospital General De Cardenas, Tabasco, México

    Nov 1, 2013, 00:00

  • Consumption Patterns, Market Characteristics and Regulation in the Pharmaceutical Industry- Evidence from Two Therapeutic Groups in Insured Population in Argentina

    Nov 1, 2013, 00:00

  • Treatments for EGFR Mutation Positive NSCLC – A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in Spain

    Nov 1, 2013, 00:00

  • Correlation Between Montgomery-Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory II (BDI-II) in Patients with Focal Epilepsy

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico

    Nov 1, 2013, 00:00

  • Comparison of Treatment Satisfaction in Patients with Asthma Taking Leukotriene Modifiers Verus Those Taking Inhaled Corticosteroids

    Nov 1, 2013, 00:00

  • Health Related Quality of Life of Patients with Bladder Cancer in Hungary

    Nov 1, 2013, 00:00

  • A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic Review

    Nov 1, 2013, 00:00

  • Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in Fran The Recode Study

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis

    Nov 1, 2013, 00:00

  • Troika in Portugal- Pharmaceutical Sector from Paper to Reality

    Nov 1, 2013, 00:00

  • Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies

    Nov 1, 2013, 00:00

  • A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian Cancer

    Nov 1, 2013, 00:00

  • How University Hospital of Crete Succeeded in Decreasing Cytostatics’ Budget in 2012?

    Nov 1, 2013, 00:00

  • Diferencias En La Consecución De Información Sobre Costos Del Manejo De La Diabetes Mellitus En Colombia

    Nov 1, 2013, 00:00

  • Assessing the Future Burden of Renal Replacement Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • The French Public Health Care System- An Original Way for Cost Saving

    Nov 1, 2013, 00:00

  • Indirect Costs of Systemic Lupus Erythematosus-Related Absenteeism in Poland- An Analysis Based on Social Insurance Institution Data

    Nov 1, 2013, 00:00

  • Benefits of Vildagliptin Plus Metformin Combination Therapy in Type 2 Diabetes Mellitus (T2DM) from Patient’s Perspective- Quality of Life (QoL) and Hypoglycemia Burden Analysis

    Nov 1, 2013, 00:00

  • Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Comparison of Markov and Discrete Event Simulation Modeling Techniques with Application to Cost Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) - A Confirmatory Factor Analysis

    Nov 1, 2013, 00:00

  • Therapy Escalation Thresholds and the Potential for Biased Cost Effectiveness Analysis When Failing to Sample Baseline HbA1c in Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina- Disease Burden Component

    Nov 1, 2013, 00:00

  • Multi-Criteria Benefit-Risk Assessment of Biological Agents in the Treatment of Moderate to Severe Psoriais- A Stochastical Approach

    Nov 1, 2013, 00:00

  • Estimación De La Costo-Efectivadad Del Uso De Daptomicina Vs Vancomicina En Pacientes Con Bacteriemia Y/O Endocarditis Por S. Aureus Resistente a Meticilina

    Nov 1, 2013, 00:00

  • EQ-5D-5L Crosswalk Value Set for Poland

    Nov 1, 2013, 00:00

  • Health Care Costs Associated with Chronic Hepatitis C Infection in Europe

    Nov 1, 2013, 00:00

  • Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context

    Nov 1, 2013, 00:00

  • Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma

    Nov 1, 2013, 00:00

  • Importance of Subgroup Analyses for Health Technology Assessments

    Nov 1, 2013, 00:00

  • Bivariate Indirect Comparison Meta-Analysis Model in Economic Evaluation of Cancer Treatments

    Nov 1, 2013, 00:00

  • Interruption/Bridging of VKA Treatment of Patients with Atrial Fibrillation- Analysis of Incidence and Clinical Outcomes Based on a German Claims Based Data Set

    Nov 1, 2013, 00:00

  • Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008

    Nov 1, 2013, 00:00

  • A Study of A. Baumannii in a Tertiary Care Hospital with Consideration to Risk Factors of Infection and Resistance Pattern

    Nov 1, 2013, 00:00

  • The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom- Is Current Practice Consistent with the 2012 ESC Recommendations?

    Nov 1, 2013, 00:00

  • Estimating Prevalence of Prostate Cancer Clinical States Using a Dynamic Patient Progression Model

    Nov 1, 2013, 00:00

  • The Nice Medical Technology Evaluation Programme (MTEP) – Insights for Manufacturers Considering Notification

    Nov 1, 2013, 00:00

  • Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results from the Rapid-axSpA ...

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials- A Content Validity and Psychometric Performance Review

    Nov 1, 2013, 00:00

  • Comparison of Drug Assessments in France, Germany and the United Kingdom- Is European HTA a Reality?

    Nov 1, 2013, 00:00

  • Pre-Financing Function of the Pharmaceutical Full-Line Wholesale Sector in the European Union

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Infant Pneumococcal Vaccination in the Netherlands

    Nov 1, 2013, 00:00

  • Faulty Connections- Can Criticisms of Network Meta-Analysis in Nice Submissions Be Avoided?

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Ranibizumab in the Treatment of the Diabetic Retinopathy in the Russian Federation

    Nov 1, 2013, 00:00

  • Impact of Value Communication in Decision Making- An Approach to the Treatment of Type 2 Diabetes in Portugal

    Nov 1, 2013, 00:00

  • Profile of Back Pain Sufferers Across 5EU Countries

    Nov 1, 2013, 00:00

  • Cell Therapies- Assessing the Patient Access Opportunities and Challenges That Lie Ahead

    Nov 1, 2013, 00:00

  • Statins in Canada- The Case for Disinvestment

    Nov 1, 2013, 00:00

  • Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

    Nov 1, 2013, 00:00

  • Reducing the Length of Antibiotic Prophylaxis in Clinical Conditions

    Nov 1, 2013, 00:00

  • Integrating the Long-Term Health Burden of Oral Corticosteroids in the Cost-Effectiveness of Omalizumab

    Nov 1, 2013, 00:00

  • Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a Idade

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients with Prostate Cancer in the United States

    Nov 1, 2013, 00:00

  • Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States

    Nov 1, 2013, 00:00

  • Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in Turkey

    Nov 1, 2013, 00:00

  • Costs Associated with the Impact of Progressive Multiple Sclerosis- Insights from a Three Year Clinical Trial (The Cupid Trial)

    Nov 1, 2013, 00:00

  • Resource Use of Non-Small Cell Lung Cancer in Slovakia

    Nov 1, 2013, 00:00

  • Analysing the Access to Priority Health Services in the Adolescent Population in Six Provinces in Northern Argentina

    Nov 1, 2013, 00:00

  • Economic Evaluation of Intravenous Iodinated Contrast Media in Italy

    Nov 1, 2013, 00:00

  • The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival

    Nov 1, 2013, 00:00

  • Costs Comparison of Cutaneous Drug Reactions Treatment Divided by Diagnosis Groups

    Nov 1, 2013, 00:00

  • From “Generic Scheme” to “Brand-Generic Scheme”- The Effect of New Policy (2003-2004) on Efficiency of Iranian Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • User and Treatment Characteristics of Oral Contraceptives in the European Union

    Nov 1, 2013, 00:00

  • Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries

    Nov 1, 2013, 00:00

  • Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context

    Nov 1, 2013, 00:00

  • Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective- A Retrospective Analysis of the Orizon Database

    Nov 1, 2013, 00:00

  • Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids- A Systematic Review and Indirect Treatment Comparison

    Nov 1, 2013, 00:00

  • Changes in Patient-Reported Outcomes Among Pediatric Leukemia and Lymphoma Patients During the First 2-Years Post Allogeneic Stem Cell Transplantation (alloSCT)

    Nov 1, 2013, 00:00

  • Poder Popular Y Regulación Del Precio De Los Medicamentos En Venezuela

    Nov 1, 2013, 00:00

  • The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries

    Nov 1, 2013, 00:00

  • Costo Efectividad Del Antibiótico Oral Vs. Local En Mujeres No Gestantes Con Flujo Vaginal Sugestivo De Vaginosis Bacteriana En Colombia

    Nov 1, 2013, 00:00

  • A Lei De Acesso À Informação Fortalece O Papel Da Avaliação De Tecnologias Em Saúde (ATS) De Fornecer Informações Sólidas E Transparentes Aos Usuários Do Sistema Único De Saúde

    Nov 1, 2013, 00:00

  • Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy

    Nov 1, 2013, 00:00

  • Revisión De Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

    Nov 1, 2013, 00:00

  • A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro

    Nov 1, 2013, 00:00

  • Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...

    Nov 1, 2013, 00:00

  • The Future of Individual Funding Requests in Clinical Commissioning Groups Era

    Nov 1, 2013, 00:00

  • The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis - Khoala Study

    Nov 1, 2013, 00:00

  • A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses in Borderline Personality Disorder

    Nov 1, 2013, 00:00

  • Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic Cardiomyopathy

    Nov 1, 2013, 00:00

  • Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in Iran

    Nov 1, 2013, 00:00

  • Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization- National Estimates for Medicare Beneficiaries, 2002 to 2009

    Nov 1, 2013, 00:00

  • Prevention of Gram-Positive Infections in Peritoneal Dialysis Patients – A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS)- Operational Setup for a Multi-Country, Multi-Center Study

    Nov 1, 2013, 00:00

  • Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil- To Know to Better Manage

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Screen or Not to Screen for Peripheral Arterial Disease- Guidance from a Decision Model

    Nov 1, 2013, 00:00

  • Cost-Utility of Rheumatoid Arthritis Monotherapy with Tocilizumab in Spain

    Nov 1, 2013, 00:00

  • Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall- A Systematic Review

    Nov 1, 2013, 00:00

  • Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing- Impact of Generic Prescribing on Cost

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Nov 1, 2013, 00:00

  • A Non-Interventional Retrospective Evaluation of Resources Consumed During the Provision of Care for Overactive Bladder Syndrome- A Real World Evaluation- German Perspective (The Reduce Study)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

    Nov 1, 2013, 00:00

  • Análise Custo-Minimização (ACM) Do Cloridrato De Valganciclovir Comparado Com Ganciclovir Na Profilaxia Da Infecção Por CMV Em Transplantados Renais

    Nov 1, 2013, 00:00

  • Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012

    Nov 1, 2013, 00:00

  • Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento Cardiovascular

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ioversol Versus Iohexol for Diagnostic Procedures

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran

    Nov 1, 2013, 00:00

  • Self-Monitoring of Blood Glucose with Insulin Analogues- Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin Analogues

    Nov 1, 2013, 00:00

  • The Efficacy of the Extra Front Loading Smoking Cessation Counselling Sessions on the Abstinence Rate Compared with Usual Care Used in Quit Smoking Clinic in Penang, Malaysia

    Nov 1, 2013, 00:00

  • Loss of Productivity in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling

    Nov 1, 2013, 00:00

  • Epidemiology for Oncological Drugs Regarding the Benefit Dossier Preparation in Germany

    Nov 1, 2013, 00:00

  • Patient Networks as a Data Source for Patient Reported Outcomes Research. Carenity Experience

    Nov 1, 2013, 00:00

  • Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population

    Nov 1, 2013, 00:00

  • Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients- Comparison with Matched Controls

    Nov 1, 2013, 00:00

  • The Influence of HAQ Utility Mapping Algorithms on the Cost-Effectiveness of Second Line Biologics for Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Colágena-Polivinilpirrolidona En El Tratamiento De Osteartrosis De Rodilla I-Ii Frente Al Cuidado Estandar Establecido En Los Protocolos Vigentes De Las Instituciones Publicas En México

    Nov 1, 2013, 00:00

  • Adherence to Antiretroviral Therapy Among HIV-Infected Patients Attending to a University Infectious Diseases Clinic in Venezuela

    Nov 1, 2013, 00:00

  • Quality Indicators of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Programme

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia

    Nov 1, 2013, 00:00

  • Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United States

    Nov 1, 2013, 00:00

  • Value Judgments in Health Technology Assessment Process in Brazil

    Nov 1, 2013, 00:00

  • Cost Savings in the Hungarian Care Managing Programme

    Nov 1, 2013, 00:00

  • Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia- Baseline Characteristics of Patients

    Nov 1, 2013, 00:00

  • Burden of Infusion-Related Costs and Staff Time for Rheumatoid Arthritis in the Hospital Setting

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Ioxaglato Versus Iodixanol En Angiografía Coronaria

    Nov 1, 2013, 00:00

  • Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe- Acesso E Impacto Econômico Em Um Hospital Universitário

    Nov 1, 2013, 00:00

  • Attitudes of Physicians Toward Implementing Shared Medical Appointments at National Guard Family Medicine Centers in Riyadh

    Nov 1, 2013, 00:00

  • Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC)- A Number-Needed-To-Treat (NNT) Analysis

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por Atonía Uterina En Pacientes Con Factores De Riesgo En Colombia

    Nov 1, 2013, 00:00

  • Dabigatran Etexilate in Prevention of Stroke for Nonvalvular Atrial Fibrillation Patients in Turkish Health Care Setting; A Study on Cost Containment of Social Security Institution (SSI)

    Nov 1, 2013, 00:00

  • Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Two-Way Sensitivity Analysis- Showing the Impact of Correlated Parameters in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Comparing Copd Costs By Exacerbation Frequency and Dyspnoea Level in a Primary Care Setting in the United Kingdom

    Nov 1, 2013, 00:00

  • The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs

    Nov 1, 2013, 00:00

  • Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology- A Willingness-To-Participate Study

    Nov 1, 2013, 00:00

  • Validity of QOL Impact Attributions to Specific Diseases- A Multitrait-Multimethod Comparison

    Nov 1, 2013, 00:00

  • Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating Tuberculosis

    Nov 1, 2013, 00:00

  • Long-Term Fiscal Implications of Funding Assisted Reproductive Therapies- A Generational Accounting Model for Spain

    Nov 1, 2013, 00:00

  • The Association Between Severity of ‘Average’ Pain (NPRS) and the EQ-5D Index in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • Length of Stay and Outcomes for Adolescents Treated for Substance Use Disorder- An Analysis of Dose Respose Using Propensity Scores

    Nov 1, 2013, 00:00

  • Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil

    Nov 1, 2013, 00:00

  • 4-Valent Vaccine Patients – Statistical Assessment of a New Estimation Methodology

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Lighterlife Total as a Treatment for Obesity in the United Kingdom

    Nov 1, 2013, 00:00

  • The Estimated Survival of Patients with Double Refractory Chronic Lymphocytic Leukaemia; A Reanalysis of NICE TA202 Using Bayesian Methodology to Model Observed Data

    Nov 1, 2013, 00:00

  • Assessing the Fiscal Consequences of Immunizing the Female and Male Population Against Human Papillomavirus (HPV) in Germany

    Nov 1, 2013, 00:00

  • Assessment of Generic Drug Policy Implementation by Measuring Persistence with Antihypertensive Drug Therapies After Patent Expiry

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Dorsopathia Diseases in Hungary

    Nov 1, 2013, 00:00

  • WITHDRAWN

    Nov 1, 2013, 00:00

  • Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid Tumors

    Nov 1, 2013, 00:00

  • A Systematic Review of Patient Reported Outcomes in Glaucoma

    Nov 1, 2013, 00:00

  • An Overview of Domestic Cancer Drugs in Turkey- 2008-2012

    Nov 1, 2013, 00:00

  • Argentina’s Generic Drug Law- Was It Successful?

    Nov 1, 2013, 00:00

  • An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

    Nov 1, 2013, 00:00

  • The Effectiveness of Statins in the Treatment of Cardiovascular Disease- Cross-Sectional Study with Paired Groups from Electronic Patient Records

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Study of Nutrition Support (NS) Usage During Intensive Treatment

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Acromegaly in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Alendronate Therapy for Secondary Prevention of Osteoporotic Fractures

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Detemir in T2DM Patients Poorly Controlled with NPH Insulin in Poland

    Nov 1, 2013, 00:00

  • EVPI Curves in Practice

    Nov 1, 2013, 00:00

  • Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings- An Individual Patient Data Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates

    Nov 1, 2013, 00:00

  • Efficacy of Long-Acting Injectable Antipsychotic Therapies in Maintenance Treatment of Schizophrenia- A Mixed Treatment Comparison (MTC) of Double-Blind Randomized Clinical Trials

    Nov 1, 2013, 00:00

  • Price Differences Triggered by the Availability of Biosimilars in Developed Countries

    Nov 1, 2013, 00:00

  • Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists- Analysis of Thin and Pharmo Databases

    Nov 1, 2013, 00:00

  • Disease Burden in Epilepsy Associated with Tuberous Sclerosis Complex- Systematic Review

    Nov 1, 2013, 00:00

  • A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular Disease

    Nov 1, 2013, 00:00

  • Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia- A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation Antipsychotics

    Nov 1, 2013, 00:00

  • Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments

    Nov 1, 2013, 00:00

  • Developing a Population-Based Dementia Registry Focusing on Patients and Carer Needs- Methodological Challenges

    Nov 1, 2013, 00:00

  • Clinical Benefits of Immunosuppression Therapy in Renal Trasplant Patients. Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Psoriasis Patients’ Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

    Nov 1, 2013, 00:00

  • Predictor Factors for the Presence of Post Herpetic Neuralgia at 3 Months in Herpes Zoster Patients Aged 50 and Over in Italy- Results from a Gp-Based Observational Prospective Multicenter Study

    Nov 1, 2013, 00:00

  • Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital Admission

    Nov 1, 2013, 00:00

  • Scoring the Center for Epidemiologic Studies – Depression Scale- Which Items Go Where?

    Nov 1, 2013, 00:00

  • Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment- Results of a Survey Among French Patients

    Nov 1, 2013, 00:00

  • What Value Can Operational Feasibility Studies Bring to Post Marketing Observational Studies (PMOS)? Example of Feasibility Study Performed in Eastern Europe to Assess Hepatitis C Viral Disease/Patient Management in Real World Setting

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • A Comparison of German Benefit Assessments by G-Ba, IQWiG and Manufacturers

    Nov 1, 2013, 00:00

  • Analysis of Brazilian Public Funding Process for New Biologic Drugs

    Nov 1, 2013, 00:00

  • Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the SP 500?

    Nov 1, 2013, 00:00

  • Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)

    Nov 1, 2013, 00:00

  • The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome Measure

    Nov 1, 2013, 00:00

  • Indirect Treatment Comparison and Economic Evaluation of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in the Netherlands

    Nov 1, 2013, 00:00

  • Clinical Effectiveness of Lacosamide and Its Impact on Concomitant Antiepileptic Drugs Consumption in the Czech Republic

    Nov 1, 2013, 00:00

  • Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty

    Nov 1, 2013, 00:00

  • Hemangioma Family Burden- Creation of a Specific Questionnaire

    Nov 1, 2013, 00:00

  • Biological Agents in the Treatment of Moderate to Severe Psoriasis- A Pharmacoeconomic Analysis

    Nov 1, 2013, 00:00

  • Haemophilia A- Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in Fran We Should Compare the Cost Per Patient Instead of the Price Per Unit

    Nov 1, 2013, 00:00

  • Eliciting the Relative Importance of Key Elements for Benefit-Risk Assessment- A Comparison Among General Population, Health Authority and Medical Doctors

    Nov 1, 2013, 00:00

  • Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

    Nov 1, 2013, 00:00

  • Developing a Publication Strategy in the Context of Outcome Research- A Review of the Literature

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United States

    Nov 1, 2013, 00:00

  • Increased Risk of Cancer Incidence Associated with Repeat Medical Imaging- Designing Better Clinical Trial Protocols

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Trasplante Renal Comparado Con La Diálisis En Colombia

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results of the Rapid ...

    Nov 1, 2013, 00:00

  • Predicting Health Care Costs in Asthma Using the EQ-5D Index Score

    Nov 1, 2013, 00:00

  • Análisis Economico De La Profilaxis Secundaria Versus El Tratamiento a Demanda De Una Cohorte De Pacientes Colombianos Con Hemofilia a Y B Severa

    Nov 1, 2013, 00:00

  • Impacto De La Diabetes Sobre La Productividad En Argentina

    Nov 1, 2013, 00:00

  • The Direct Costs of Drug-Induced Skin Reactions in Poland

    Nov 1, 2013, 00:00

  • Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC)- Mean Overall Survival (OS) in a “Better Responders” Patient Population of the Velour Trial

    Nov 1, 2013, 00:00

  • Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)

    Nov 1, 2013, 00:00

  • Perception of Users of Drug Distribution Program in Brazil

    Nov 1, 2013, 00:00

  • The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in Sweden

    Nov 1, 2013, 00:00

  • Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012

    Nov 1, 2013, 00:00

  • Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients- 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective

    Nov 1, 2013, 00:00

  • Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial

    Nov 1, 2013, 00:00

  • Investigating the Validity of the UKPDS Outcomes Equations in Current Clinical Practice

    Nov 1, 2013, 00:00

  • A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF)

    Nov 1, 2013, 00:00

  • Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis- What to Do When a Biologic Fails

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction

    Nov 1, 2013, 00:00

  • Formulations of Amphotericin B for the Treatment of Fungal Infections in Patients with HIV/AIDS

    Nov 1, 2013, 00:00

  • How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

    Nov 1, 2013, 00:00

  • Improvements in Physical Function, Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis Treated with Golimumab- Sub-Analysis of Latin American Patients Enrolled in Mulitcentre Phase III Clinical Trials

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Antimicrobials as Treatment for Patients with Complicated Skin and Soft Tissues Infections- A Comparison Between Ceftaroline, Linezolid and Vancomycin in the Russian Health Care

    Nov 1, 2013, 00:00

  • Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • Efficacy and Tolerability of CT-Guided Epidural Steroid Injections and Pharmacotherapy for Managing Chronic Low Back Ache with Radiculopathy

    Nov 1, 2013, 00:00

  • Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis in Spain

    Nov 1, 2013, 00:00

  • Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates

    Nov 1, 2013, 00:00

  • Re-Engineering of the Distribution of Drugs in the Hospital. TOC Application and TRZ

    Nov 1, 2013, 00:00

  • Costos Económicos Asociados A Secuelas De Meningitis En Colombia

    Nov 1, 2013, 00:00

  • Measurements of Adherence to Oral Therapies Among Brazilian Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ranibuzumab for the Treatment of Myopic Choroidal Neovascularization in Canada

    Nov 1, 2013, 00:00

  • Potential Predictors of Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Hepatitis a Vaccine Policy Process in 6 Countries – Factors Influencing Potential Adoption

    Nov 1, 2013, 00:00

  • The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic

    Nov 1, 2013, 00:00

  • The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation- A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need

    Nov 1, 2013, 00:00

  • Psychometric Properties of the Hypoglycemia Perspectives Questionnaire (HPQ) in Type 2 Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Systematic Review- The Economic Burden of Crohn’s Disease in Europe in Adults and Children

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United States

    Nov 1, 2013, 00:00

  • How Can Health Economic Assessment Methods Help Decision Making in Portfolio Development

    Nov 1, 2013, 00:00

  • Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control- Pooled Analysis of 17,516 Patients from Seven Valsartan Studies

    Nov 1, 2013, 00:00

  • Comprehensive Overview- Efficacy, Tolerability and Cost- Effectiveness of Irbesartan

    Nov 1, 2013, 00:00

  • Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Pulmonary Veins Isolation with Cryo Technique

    Nov 1, 2013, 00:00

  • Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

    Nov 1, 2013, 00:00

  • Resource Use and Disease Progression Among HCV-Positive Patients

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Multiple Outcomes- A Simulation Study and Application

    Nov 1, 2013, 00:00

  • How Burdensome Is Completion of Electronic Patient-Reported Outcomes (ePRO)? Item Completion Times and Qualitative Evidence from Studies in Four Different Health Conditions

    Nov 1, 2013, 00:00

  • Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in France

    Nov 1, 2013, 00:00

  • Economic Evaluation of Mandibular Advancement Device to Treat Obstructive Sleep Apnea

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care System

    Nov 1, 2013, 00:00

  • Using the Delphi Method for Selecting Medical Technologies Under Budget Constraints- A Feasibility Study

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens

    Nov 1, 2013, 00:00

  • Managed Entry Agreements and Orphan Drugs- A European Comparative Study (2006-2012)

    Nov 1, 2013, 00:00

  • Use of Beta Blocking Agents in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Incidence of Anastomotic Leaks After Colorectal Surgeries Using Hospital Episode Statistics in the United Kingdom

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil- Results from a 12-Month Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • Toxocariasis- A Disease of High Prevalence But Forgotten

    Nov 1, 2013, 00:00

  • Reasons Given by the European Medicines Agency for Revising Disease-Specific Scientific Guidelines

    Nov 1, 2013, 00:00

  • Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess the Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU)

    Nov 1, 2013, 00:00

  • The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Renal Post-Transplant Prophylaxis with Belatacept in Colombia

    Nov 1, 2013, 00:00

  • A Systematic Review of Patients’ Treatment Satisfaction and/or Preference Patient-Reported Oucomes Measures Used in Clinical Trials

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

    Nov 1, 2013, 00:00

  • Future Costs Inclusion in Published Economic Evaluations- What Is the Current Situation?

    Nov 1, 2013, 00:00

  • The Costs of Managing Genital Warts in the UK by Devolved Nation- England, Scotland, Wales and Northern Ireland

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization Costs Related to Anaemia Management in Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context- The French Case

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary Care

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Accepting Submissions with ICERs Higher Than the Threshold

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • Cost Analysis of Proton Pump Inhibitors in the Treatment of Ulcer Duodenum in Ukraine

    Nov 1, 2013, 00:00

  • 2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS

    Nov 1, 2013, 00:00

  • The Importance of Sensitivity Analyses in Health Technology Assessments

    Nov 1, 2013, 00:00

  • Cost of Influenza in Germany

    Nov 1, 2013, 00:00

  • Projeção De Gastos Com Medicamentos De Uso Crônico (Ambulatorial)

    Nov 1, 2013, 00:00

  • Analysis of Published Health Technology Assessments (HTA) in Russia and Its Place in Russian Reimbursement System

    Nov 1, 2013, 00:00

  • Dealing with Zero Cells in Sparse Networks in Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Inference on Incremental Cost Effectiveness Thresholds Influencing Nice Decisions- A Bayesian Analysis

    Nov 1, 2013, 00:00

  • Active-Implantable Cardiac Devices- Is There Room for Cost Savings in Portuguese Hospitals?

    Nov 1, 2013, 00:00

  • A Systematic Review on the Effect of Behavioral Versus Surgical Intervention on Obese Patients’ Psychological Well-Being

    Nov 1, 2013, 00:00

  • Mood Stabilizers and Atypical Antipsychotics in Maintenance Therapy for Bipolar Disorder- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Copyright/Subscription

    Nov 1, 2013, 00:00

  • Use of Surrogate Outcomes in Health Technology Assessments (HTAs)

    Nov 1, 2013, 00:00

  • The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment

    Nov 1, 2013, 00:00

  • Disease Burden of Ischemic Stroke Along First Year Post-Stroke in Spain

    Nov 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106 (current)
  • 107
  • 108
  • 109
  • 110
  • »